Walgreens Boots Alliance Inc. (WBA)

55.30
NASDAQ : Retail Trade
Prev Close 55.94
Day Low/High 55.27 / 56.17
52 Wk Low/High 49.03 / 86.31
Avg Volume 4.56M
Exchange NASDAQ
Shares Outstanding 903.14M
Market Cap 50.52B
EPS 5.10
P/E Ratio 10.99
Div & Yield 1.83 (3.26%)
'Death by Amazon' Greatly Exaggerated

'Death by Amazon' Greatly Exaggerated

Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.

Rite Aid Shareholders Cheer Merger Failure, Call on CEO to 'Put House In Order'

Rite Aid Shareholders Cheer Merger Failure, Call on CEO to 'Put House In Order'

Rite Aid CEO John Standley faces shareholders's scrutiny after the merger flop.

Will Rite Aid End Up Like Blockbuster?

Will Rite Aid End Up Like Blockbuster?

After a failed merger with Albertsons, Rite Aid faces a difficult time on its own in a changing landscape.

Rite Aid's Rotten Week: How Will It Now Compete Against Walgreens, CVS?

Rite Aid's Rotten Week: How Will It Now Compete Against Walgreens, CVS?

A week of bad news for Ride Aid may be good news for its competitors Walgreens and CVS.

Amazon Aims to Boost Sales of Its Private Label Products This Prime Day

Amazon Aims to Boost Sales of Its Private Label Products This Prime Day

Prime Day 2018 is expected to generate $3.4 billion in sales, according to Coresight Research.

Jim Cramer: Why Investing in FANG Stocks Refuses to Get Long in the Tooth

Jim Cramer: Why Investing in FANG Stocks Refuses to Get Long in the Tooth

Here's to FANG for once again exciting and enthralling and defying all of the negatives.

Here's What You Need to Know on Thursday

Here's What You Need to Know on Thursday

Let's go over the market on Thursday.

Chipotle Won't Release Financial Forecasts So Investors Sell: LIVE MARKETS BLOG

Chipotle Won't Release Financial Forecasts So Investors Sell: LIVE MARKETS BLOG

Shares were down 8% Thursday.

Amazon's Acquisition of PillPack is Harming Traditional Pharmacies

Amazon's Acquisition of PillPack is Harming Traditional Pharmacies

Amazon's acquisition of PillPack is hitting traditional pharmacies.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Markets were routed Monday.

Four Cheap 'Dividend Aristocrats' to Buy Now

Four Cheap 'Dividend Aristocrats' to Buy Now

These stocks are selling at historically low earnings multiples, but have raised their dividends for decades.

A Change in the Pattern

A Change in the Pattern

Stocks traded in a different pattern Wednesday, as big tech names dominated.

Jim Cramer: With GE It's So Difficult to Believe We Are at the Bottom

Jim Cramer: With GE It's So Difficult to Believe We Are at the Bottom

I know there's plenty of irony to go around for this once great manufacturer to be replaced in the Dow by a drug store chain.

Walgreens Boots Joins a Very Special Club

Walgreens Boots Joins a Very Special Club

Drugstore giant's charts were showing positive signs even before its inclusion in the Dow Jones Industrial Average.

End of an Era for the Dow Industrials: Market Recon

End of an Era for the Dow Industrials: Market Recon

GE is getting tossed from the index, after 111 consecutive years.

GE Loses Its Spot on the Dow and 4 Other Stories to Watch Wednesday Morning

GE Loses Its Spot on the Dow and 4 Other Stories to Watch Wednesday Morning

These are the stories pushing futures higher ahead of Wednesday's opening bell.

Walgreens Presents Best Bargain in a Decade

Walgreens Presents Best Bargain in a Decade

The drugstore chain's price to fair value has not been this favorable since the Crash of 2008-2009.

What Theranos' 'Massive Fraud' Can Teach Biotech Investors

What Theranos' 'Massive Fraud' Can Teach Biotech Investors

Theranos, once a Silicon Valley unicorn promising investors and partners like Walgreens a simple blood-testing solution, is a cautionary tale for biotech investors.

Follow the Money -- Buy CVS

Follow the Money -- Buy CVS

Few companies can match CVS' long-term record and top-quality corporate metrics.

Follow the Money -- Buy CVS

Follow the Money -- Buy CVS

Insiders are buying CVS on the cheap. You should too.

Jim Cramer: Sprint/T-Mobile Merger Is Crazy ... But Just Might Work

Jim Cramer: Sprint/T-Mobile Merger Is Crazy ... But Just Might Work

If anyone can sell it to antitrust regulators, T-Mobile CEO John Legere can.

Jim Cramer: It's All About Expectations

Jim Cramer: It's All About Expectations

Earnings season is already seeing some wacky effects.

Second Quarter Predictions

Second Quarter Predictions

Better-than-expected earnings will help soothe market jitters in the second quarter.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

It was another down day for markets across the board Wednesday.

Bullish Divergences on Walgreens Worthy of Attention

Bullish Divergences on Walgreens Worthy of Attention

Charts suggest there may be hope for Walgreens bulls.

3 Ways to Keep Yourself From Blowing Up on An Awful Day: Market Recon

3 Ways to Keep Yourself From Blowing Up on An Awful Day: Market Recon

The keys? Preparation, Discipline and Plan of Action.

Just What the Doctor Ordered

Just What the Doctor Ordered

Walgreen's Boots hasn't been this cheap versus earnings since 2012.

Walgreens Boots Alliance Shares Look Vulnerable

Walgreens Boots Alliance Shares Look Vulnerable

Volume and other indicators suggest more weakness ahead.